/
DCF Valuation
Base-case fair value
$393.02
Intrinsic $524.02 · 25% MOS
Current price: $391.27
Base-case summary
Our base-case DCF for Elevance Health, Inc. (ELV) projects 10 years of free cash flow growth at 2.0% for years 1–5 and 1.0% for years 6–10, anchored to a default 8% growth assumption, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $6.5B in trailing free cash flow, this produces an intrinsic value of $524.02 per share. A 25% safety margin gives a fair value of $393.02, suggesting the stock is currently 0% undervalued against the $391.27 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$6.5B
Cash & equivalents
$35.6B
Total debt
$31.8B
Shares outstanding
220M